Effectiveness of a novel, fixed dose combination of netupitant and palonosetron in prevention of chemotherapy induced nausea and vomiting: A real-life study from India

doi:10.5306/wjco.v11.i8.606

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6410)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

225

WORD

165

HTML

2191

Figures (1-1)

233

Tables (1-3)

254

Sum=3068

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

411

Download

928

Sum=1339

Publishing Process of This Article

Item

Count

Browse

647

Download

1356

Sum=2003

Aug 24, 2020 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Oncol. Aug 24, 2020; 11(8): 606-613
Published online Aug 24, 2020. doi: 10.5306/wjco.v11.i8.606

Full Size Figure Download Figure

Figure 1 Study flow chart. Study flow: Medical records and patient dairies were evaluated for incidence and severity of nausea-vomiting, time period was form the time chemotherapy was administered to 120 h ( day 1 to day 5) to look for complete response in acute, delayed and overall phase. NEPA: Netupitant and palonosetron.

Citation: Vaswani B, Bhagat S, Patil S, Barkate H. Effectiveness of a novel, fixed dose combination of netupitant and palonosetron in prevention of chemotherapy induced nausea and vomiting: A real-life study from India. World J Clin Oncol 2020; 11(8): 606-613
URL: https://www.wjgnet.com/2218-4333/full/v11/i8/606.htm
DOI: https://dx.doi.org/10.5306/wjco.v11.i8.606